Home » Market News » DirectorsTalk Highlights » Plant Health Care Plc ProAct® Wins Top Industry Award
Plant Health Care Plc

Plant Health Care Plc ProAct® Wins Top Industry Award

Chris Richards, Executive Chairman and Interim CEO of Plant Health Care noted: “This award is recognition that Plant Health Care, as a science-based company, can bring new benefits to growers with low toxicity, biological products. We now plan to take these results from Spain into other key citrus growing areas, such as Florida, South Africa and North Africa.”

Plant Health Care Plc (LON:PHC), a leading provider of novel patent-protected biological products to global agriculture markets, today announced ProAct was named Best New Biological Product on 12th November in London at the Agrow Awards.

Highlights:

– ProAct (Harpin ab) has been recognised as Best New Biological Product at the Agrow Awards, a prestigious global industry event

– Research has shown how ProAct works to improve citrus quality, leading to increased production of export quality fruit

– Plant Health Care is leveraging these results to drive sales into citrus and other fruits into export fruit markets in the Americas and Africa

ProAct, which is based on Harpin ab, improves the quality of fruit, so that more are graded for export, thereby increasing returns to growers. Research at Instituto Valenciano de Investigaciones Agrarias, in collaboration with Plant Health Care, showed that ProAct stimulates the mobilisation of calcium in the plant cell wall of citrus fruits, leading to a stronger peel, which is less susceptible to fruit splitting. Moreover ProAct, as a biological product, is certified for residue free fruit and vegtables.

Angel Marin, General Manager of Plant Health Care España S.A., received the award on behalf of the Company.

Harpin ab, the active ingredient in ProAct, has been used on over 13 million acres on multiple crops. Sales have been growing at over 20% a year for the past 5 years.

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.